Who Paid My Doc
SELECT-1st relapse after len-containing regimen
Research payments
$901,401
Through program year 2021, $901,401 in research payments was reported against SELECT-1st relapse after len-containing regimen, across 35 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $901,401 | 35 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jason Melear Austin, TX Named on 4 payments
- Amanda Gillespie-Twardy Roanoke, VA Named on 3 payments
- Edward Faber Cincinnati, OH Named on 3 payments
- Harris Naina Flower Mound, TX Named on 3 payments
- Habte Yimer Tyler, TX Named on 3 payments
- Terri Parker New Haven, CT Named on 3 payments
- Timothy Larson Minneapolis, MN Named on 3 payments
- Rami Haddad Oak Lawn, IL Named on 3 payments
- Robert Rifkin Denver, CO Named on 3 payments
- Moshe Levy Dallas, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.